Health and economic outcomes of vancomycin-resistant enterococci

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2223-2228

  Carmeli, Yehuda ^a,b   Eliopoulos, George ^a   Mozaffari, Essy ^c   Samore, Matthew ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c PFIZER INC   (United States)

^d UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; METICILLIN; METRONIDAZOLE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRITICAL ILLNESS; ENTEROCOCCUS; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SURGICAL PATIENT; WOUND INFECTION;

COHORT STUDIES; COSTS AND COST ANALYSIS; CROSS INFECTION; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; VANCOMYCIN RESISTANCE;

EID: 0037190708     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2223     Document Type: Article

References (19)

1. Acar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis. 1997; 24(suppl):S17-S18.
2. Cohen ML. Epidemiology of drug resistance: Implications for a post-antimicrobial era. Science. 1992;257:1050-1055.
3. Office of Technology Assessment, US Congress. Impacts of Antibiotic-Resistant Bacteria, OTA-H-629. Washington, DC: US Government Printing Office; 1995.
4. Holemberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev infect Dis. 1987;9:1065-1078.
5. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988;319:157-161.
6. Uttley AHC, Collins CH, Naidoo J, et al. Vancomycin-resistant enterococci. Lancet. 1988;1:57-58.
7. Public Health Service, US Department of Health and Human Services. NNIS Semiannual Report. Available at: http://www.cdc.gov/ncidod/hip/NNIS/ar_surv99.pdf. Accessed July 5, 2002.
8. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP. Vancomycin-resistant enterococcal bacteremia: Natural history and attributable mortality. Clin Infect Dis. 1996;23:1234-1239.
9. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: Does vancomycin resistance make a difference? Arch Intern Med. 1998; 158:522-527.
10. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium. Clin Infect Dis. 1996;22:663-670.
11. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and susceptible enterococcal bacteremia. Diagn Microbiol infect Dis. 2000;36:145-158.
12. Samore M, Lichtenberg D, Sauberman L, Kawachi C, Carmeli Y. A clinical data repository enhances hospital infection control. Proc AMIA Annu Fall Symp. 1997; 9:56-60.
13. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373-383.
14. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with various antibiotic agents as a risk factor for vancomycin-resistant enterococcus. Emerg Infect Dis. 2002;8:802-807.
15. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika, 1983;70:41-55.
16. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
17. Connors AF Jr, Speroff T, Dawson NV, et al, for the SUPPORT Investigators. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-897.
18. Greenland S, Drescher K. Maximum likelihood estimation of the attributable fraction from logistic models. Biometrics. 1993;49:865-872.
19. Harris A, Torres-Vierra C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. Clin Infect Dis. 1999;28:1128-1133.